Literature DB >> 31387896

In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in MTTP explain only part of LDL variability in an FH family.

Michael Winther1, Shoshi Shpitzen2, Or Yaacov2,3, Jakob Landau3, Limor Oren2, Linda Foroozan-Rosenberg2, Naama Lev Cohain4, Daniel Schurr2, Vardiela Meiner5, Auryan Szalat2,6, Shai Carmi3, Michael R Hayden1, Eran Leitersdorf2, Ronen Durst7,8.   

Abstract

We previously identified a highly consanguineous familial hypercholesterolemia (FH) family demonstrating segregation of the JD Bari mutation in the LDL receptor as well as a putative cholesterol-lowering trait. We aimed to identify genes related to the latter effect. LDL cholesterol (LDLc) values were normalized for FH affectation status, age, and gender. Using genome-wide SNP data, we examined whether known SNPs gleaned from a genome-wide association study could explain the variation observed in LDLc. Four individuals with markedly reduced LDL levels underwent whole exome sequencing. After prioritizing all potential mutations, we identified the most promising candidate genes and tested them for segregation with the lowering trait. We transfected a plasmid carrying the top candidate mutation, microsomal triglyceride transfer protein (MTTP) R634C, into COS-7 cells to test enzymatic activity. The SNP score explained 3% of the observed variability. MTTP R634C showed reduced activity (49.1 nmol/ml) compared with the WT allele (185.8 nmol/ml) (P = 0.0012) and was marginally associated with reduced LDLc in FH patients (P = 0.05). Phenotypic variability in a FH pedigree can only partially be explained by a combination of common SNPs and a rare mutation and a rare variant in the MTTP gene. LDLc variability in FH patients may have nongenetic causes.
Copyright © 2019 Winther et al.

Entities:  

Keywords:  cholesterol metabolism; diseases/dyslipidemia; familial hypercholesterolemia; gene expression/polymorphisms; genes in lipid dysfunction; genetics; low density lipoprotein; low density lipoprotein cholesterol; low density lipoprotein/assembly; microsomal triglyceride transfer protein; single nucleotide polymorphism

Mesh:

Substances:

Year:  2019        PMID: 31387896      PMCID: PMC6795082          DOI: 10.1194/jlr.M092049

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  35 in total

Review 1.  The role of the microsomal triglygeride transfer protein in abetalipoproteinemia.

Authors:  N Berriot-Varoqueaux; L P Aggerbeck; M Samson-Bouma; J R Wetterau
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

Review 2.  Phenotypic variability in familial hypercholesterolaemia: an update.

Authors:  Angelique C M Jansen; Sanne van Wissen; Joep C Defesche; John J P Kastelein
Journal:  Curr Opin Lipidol       Date:  2002-04       Impact factor: 4.776

3.  Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

Review 4.  Microsomal triglyceride transfer protein.

Authors:  J R Wetterau; M C Lin; H Jamil
Journal:  Biochim Biophys Acta       Date:  1997-04-01

5.  Evidence of a vicious cycle in mitral regurgitation with prolapse: secondary tethering attributed to primary prolapse demonstrated by three-dimensional echocardiography exacerbates regurgitation.

Authors:  Kyoko Otani; Masaaki Takeuchi; Kyoko Kaku; Nobuhiko Haruki; Hidetoshi Yoshitani; Masataka Eto; Masahito Tamura; Masahiro Okazaki; Haruhiko Abe; Yoshihisa Fujino; Yousuke Nishimura; Robert A Levine; Yutaka Otsuji
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

6.  Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype.

Authors:  S Bertolini; A Cantafora; M Averna; C Cortese; C Motti; S Martini; G Pes; A Postiglione; C Stefanutti; I Blotta; L Pisciotta; M Rolleri; S Langheim; M Ghisellini; I Rabbone; S Calandra
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

7.  The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia.

Authors:  D L Sprecher; J M Hoeg; E J Schaefer; L A Zech; R E Gregg; E Lakatos; H B Brewer
Journal:  Metabolism       Date:  1985-03       Impact factor: 8.694

8.  Identification of mutations in the apolipoprotein B-100 gene and in the PCSK9 gene as the cause of hypocholesterolemia.

Authors:  Trond P Leren; Knut Erik Berge
Journal:  Clin Chim Acta       Date:  2008-07-27       Impact factor: 3.786

9.  Second-generation PLINK: rising to the challenge of larger and richer datasets.

Authors:  Christopher C Chang; Carson C Chow; Laurent Cam Tellier; Shashaank Vattikuti; Shaun M Purcell; James J Lee
Journal:  Gigascience       Date:  2015-02-25       Impact factor: 6.524

10.  Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.

Authors:  S E Humphries; R A Whittall; C S Hubbart; S Maplebeck; J A Cooper; A K Soutar; R Naoumova; G R Thompson; M Seed; P N Durrington; J P Miller; D J B Betteridge; H A W Neil
Journal:  J Med Genet       Date:  2006-12       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.